A vascular necrosis (AVN) of the femoral head may account for 5% to 18% of hip replacements worldwide. 1 Although often idiopathic, the disease has been linked to several risk factors: alcohol consumption, smoking, human immunodeficiency virus, steroid use, systemic lupus erythematosus, hematologic disease, radiation therapy, and trauma to the hip. 1, 2 Patients with AVN often seek care at a younger age than patients with osteoarthritis and may be offered joint-sparing treatments; however, they are most frequently treated with total hip arthroplasty (THA). 3, 4 Total hip arthroplasty is an extremely high quality medical intervention with measured benefit to individual patients and society as a whole. 5 The subset of THA for treatment of AVN has been identified to be different than THA for osteoarthritis not just in age but also in several long-term outcomes, including bearing wear and incidence of dislocation. 6, 7 Current THA procedure volume has created a fiscal strain on the American health care system, garnering increased scrutiny of short-term outcomes (specifically, costly complications) as payers attempt to shift from purchasers of volume to purchasers of quality. The value proposition in which outcome per given cost is
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In addition, the Centers for Medicare & Medicaid Services (CMS) mandates the public reporting of complications and readmissions after hip and knee arthroplasty and imparts financial penalties when providers do not meet certain standards. 8 Risk-adjustment models that account for variance in presurgical conditions are imperative to allow for fair reporting of outcomes. Current risk-adjusted outcomes models include factors that increase complications after THA, including obesity, diabetes mellitus, high American Society of Anesthesiologist (ASA) class, and smoking. [9] [10] [11] [12] Past literature suggests that AVN of the femoral head is associated with a complex hip deformity and a higher patient comorbidity burden, which in turn leads to increased complication rates following arthroplasty. 4, 7, 13 However, the most recent risk-adjustment models do not include AVN as a factor that may impact risk assessment of short-term complications and readmissions. [14] [15] [16] Using a database from California, Stavrakis et al 13 argued that AVN should be included in any risk-adjusted outcomes model in their state. The purpose of the current study is to compare 30-day rates of complications, readmissions, and reoperation in patients receiving THA for AVN vs osteoarthritis using a national dataset.
Materials and Methods
Using the CPT code 27130, the authors identified 39,652 patients who underwent THA from the 2011 to 2013 in the American College of Surgeon's National Surgical Quality Improvement Program (ACS-NSQIP) database. The utility of the ACS-NSQIP as a research tool has been previously described. 17 In brief, the ACS-NSQIP is comprised of more than 450 hospitals. The hospitals vary from large urban academic centers to small community practices. Each site has a trained Surgical Clinical Nurse reviewer in charge of supervising data collection using patient charts and phone calls when necessary. The database is known to be valid and reliable. 18, 19 From the initial sample of 39,652 patients, the International Classification of Diseases, 9th edition (ICD-9) code 733.42 was used to identify patients with a diagnosis of avascular necrosis, and the ICD-9 code 715 was used to identify patients with a diagnosis of osteoarthritis. Patients with missing data, concomitant procedures, bilateral THA procedures, or a di- agnosis other than osteoarthritis or avascular necrosis of the femoral head were excluded from the analysis. The primary outcomes of interest included surgical complication, medical complication, readmission, and reoperation. All outcomes were within 30 days. Surgical complication included superficial surgical site infection (SSI), deep SSI, wound dehiscence, and prosthesis failure. Medical complications included cardiac arrest, myocardial infarction, pneumonia, unplanned intubation, pulmonary embolism, deep venous thrombosis/thrombophlebitis, on ventilator for more than 48 hours, acute renal failure, progressive renal insufficiency, urinary tract infection, stroke or cerebrovascular accident, coma, bleeding transfusion, sepsis, and septic shock. Bleeding transfusion was defined as "at least 1 unit of packed or whole red blood cells given from the surgical start time up to and including 72 hours postoperatively." 20 Autologous and allogeneic blood are equal under the ACS-NSQIP's definition. Readmission and reoperation were defined as any unplanned readmission or reoperation at the same or another hospital for a problem likely related to the principal surgical procedure. More specific definitions of the above complications may be found in the ACS-NSQIP User Guide. 20 To adjust for differences between the cohorts, all patients who met inclusion criteria and had a diagnosis of AVN were matched 1:1 to controls (patients undergoing THA for osteoarthritis or unspecified arthritis) using a predetermined propensity score algorithm accounting for variables suspected to affect the short-term complication rate following THA. [9] [10] [11] [12] 14, 15 Patients were matched for gender, age class, body mass index (BMI) class, type of anesthesia used, smoking status, diabetes mellitus, congestive heart failure within 30 days of procedure, chronic steroid use, hypertension, chronic obstructive pulmonary disease, kidney disease (on dialysis or serum creatinine above 2.0 mg/dL), bleeding disorder, preoperative hematocrit less than 21%, preoperative platelets less than 50,000/µL, and operation time greater than 2 hours (1 SD above mean).
Pearson's chi-square and Fisher's exact test were used to compare all categorical variables. For each outcomes of interest, generalized linear models were created using binary logistic regression. Demographics, comorbidities, and laboratory values used in matching were screened for inclusion in each model. Inclusion criteria for covariates were an association with the outcome of interest (P≤.20) and an event occurrence rate of 10 or more. All analyses were run at a type I error rate of 5% using SPSS version 22 software (IBM Corp, Armonk, New York).
results
After the application of exclusion criteria, 1706 patients undergoing THA for AVN were matched in a 1:1 ratio to 1706 controls. Baseline differences between cohorts were successfully eliminated through the propensity match algorithm ( Table 1) . Most patients were younger than age 59 years (64% AVN vs 63% non-AVN; P=.693), and the most common BMI class was 18.5 to 25 kg/m 2 (36% AVN vs 37% non-AVN; P=.375). The most common comorbidities in the patient sample were hypertension (50% AVN vs 50% non-AVN; P=.620) and smoking (32% AVN vs 35% non-AVN;
P=.108).
Comparison between matched cohorts (Table 2) showed that patients with AVN had a higher rate of medical complications than those without AVN (20.8% vs 15.3%, respectively; P<.001). Bleeding transfusion was the most common medical complication (Table 3) , occurring at a significantly higher rate in patients with AVN (19.6% AVN vs 13.9% non-AVN; P<.001). Urinary tract infection was the next most common complication, occurring at the same rates between the 2 groups (0.8% AVN vs 0.8% non-AVN; P=1.000). All other medical complications were comparable between the matched cohorts ( 
discussion
In this investigation, the authors utilized a well-researched national dataset designed to support quality investigations to identify a large cohort of patients with AVN undergoing THA and to assess the role of AVN in relative risk of adverse outcome following surgery. The study group was consistent with populations in other investigations of hip replacement, in which the majority of patients with AVN were younger, with healthy BMIs, and a large percentage of smokers. 4, 7, 13 Using a propensity match algorithm, the authors successfully identified a non-AVN patient cohort with similar demographic and comorbid conditions, allowing the authors to make statistically valid comparisons of outcomes of interest.
The CMS uses short-term rates of postsurgical myocardial infarction, pneumonia, sepsis, urinary tract infection, venous thromboembolism, surgical site infection, surgical site bleeding, death, readmission, and reoperation as surrogates for quality, and these outcomes serve as the outcomes of interest in this study. 8 These results suggest that AVN is associated with an increase in medical complications following THA, the majority of which are blood transfusion. After adjusting for preoperative factors (among them presurgical platelet level, hematocrit, and bleeding disorders), the current authors found a significantly higher rate of bleeding requiring transfusion in AVN patients (19.6%) compared with non-AVN patients (13.9%) undergoing THA (P<.001). As a result, the authors recommend advanced blood management strategies for patients with AVN undergoing THA. 21 This investigation is not able to establish a causative link between AVN and increased rates of blood transfusion following THA. However, the association between the 2 has been borne out in a previous study by Stavrakis et al 13 in which, using a discharge database of all hip replacements performed in California from 1995 to 2010, the authors found that 13 Their reported rate of surgical site bleeding was likely underestimated because they could only account for complications that resulted in readmissions. In contrast, the ACS-NSQIP follows patients for 30 days, includes facilities other than the original treating facility, and defines bleeding transfusion as transfusion occurring within 72 hours of surgery. According to CMS definitions, these transfusions would have been reported as "surgical site bleeding." Thus, although most recent risk-adjustment models fail to include AVN as an accounted risk variable, 14, 15 the current authors believe that the results strongly support the notion that AVN impacts complications following THA and should be considered as a covariate in any outcomes-based risk adjustment model.
In addition, the current data demonstrate that patients with AVN are twice as likely as those without AVN to be readmitted within the first month following THA. Stavrakis et al 13 also showed that patients with AVN are almost twice as likely to be readmitted. Although the reason for readmission is rarely reported in the ACS-NSQIP database, the ACS-NSQIP defines readmission similarly to CMS as "an unplanned readmission for a postoperative occurrence likely related to the principal surgical procedure." 20 Again, the current investigation does not support a specific causative link between AVN of the femoral head and readmission following THA but does argue for its inclusion as a risk variable in any quality-based risk assessment model. Prior studies on factors associated with readmission often account for comorbid conditions linked to the diagnosis of AVN but have failed to account for the isolated effect of AVN itself. 10, 22, 23 The current authors recommend that patients with AVN as a pre-arthroplasty diagnosis should be carefully monitored for postoperative events that may lead to increased likelihood of readmission. 10 The current study has several limitations. First, the grading of AVN was not assessed, so the authors were unable to comment on the complexity of deformity or bone stock available in each patient. Second, as with all administrative databases, the variables captured by the ACS-NSQIP are limited. Specifically, the magnitude and etiology of AVN, insurance status, socioeconomic variables, and reason for readmission or reoperation are largely unavailable. Furthermore, other factors related to bleeding, such as hepatic dysfunction and postoperative venous thromboembolism prophylaxis, were not captured by the ACS-NSQIP. Third, the cutoff for preoperative anemia was a hematocrit of 21%. Given the prevalence of blood disorders within patients who experience AVN, 1,2 the current authors' goal in using this cutoff was to account for patients with chronic anemia who may have had unique transfusion recommendations. Given that THA is an elective surgery, a higher threshold could have also been used and may have been more appropriate. Lastly, the most significant shortcoming is the inability to document variance in transfusion practice patterns. Quite reasonably, individual physicians and institutions have different practice patterns regarding postarthroplasty transfusion. 24, 25 To the authors' knowledge, there are no guidelines that recommend different transfusion practices for patients with AVN compared with patients with other hip-specific diagnoses undergoing THA. Furthermore, patients who were recommended for discharge to skilled nursing facilities may have had "directed transfusions" based on requirements of those facilities. Despite these shortcomings, the current findings are likely generalizable given that the study cohort represents patients from multiple care settings, treated by multiple physicians across the country with little short-term data loss.
conclusion
Avascular necrosis of the femoral head is an independent risk factor for transfusion within 72 hours of surgery and 30-day readmission following hip replacement. Accordingly, AVN should be included as a variable in any national risk-adjusted outcomes model to ensure accurate comparison of quality metrics. Furthermore, the authors hope that surgeons can now better presurgically counsel patients with AVN and take appropriate perioperative measures to mitigate risk. Given that the study was not able to account for other factors that may have influenced bleeding risk, future research is needed to establish whether there is a causative link between AVN and increased risk of bleeding and readmission following THA.
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